Patents Assigned to ORPHIT
  • Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases
    Patent number: 9468662
    Abstract: A PAT nonapeptide of formula EAKSQGGSD (SEQ ID NO: 1) can be used to treat or prevent neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. Pharmaceutical compositions containing the PAT nonapeptide can be formulated for administration by parenteral route, including the subcutaneous, intraperitoneal, intravenous or intranasal routes.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: October 18, 2016
    Assignee: ORPHIT
    Inventors: Claude Laruelle, Jamal Temsamani, Frederic Mourlane